News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,828 Results
Type
Article (14572)
Company Profile (110)
Press Release (267146)
Section
Business (91713)
Career Advice (490)
Deals (16098)
Drug Delivery (68)
Drug Development (38945)
Employer Resources (53)
FDA (6776)
Job Trends (6699)
News (157472)
Policy (14566)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (559)
Adcomms (6)
Allergies (33)
Alliances (24377)
ALS (37)
Alzheimer's disease (429)
Antibody-drug conjugate (ADC) (37)
Approvals (6820)
Artificial intelligence (105)
Autoimmune disease (9)
Automation (4)
Bankruptcy (152)
Best Places to Work (4865)
BIOSECURE Act (10)
Biosimilars (58)
Biotechnology (46)
Bladder cancer (19)
Brain cancer (15)
Breast cancer (83)
Cancer (660)
Cardiovascular disease (76)
Career advice (429)
Career pathing (11)
CAR-T (25)
Cell therapy (107)
Cervical cancer (4)
Clinical research (32701)
Collaboration (343)
Compensation (136)
Complete response letters (17)
COVID-19 (831)
CRISPR (21)
C-suite (122)
Cystic fibrosis (43)
Data (717)
Denatured (15)
Depression (12)
Diabetes (83)
Diagnostics (1500)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (15)
Drug discovery (57)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (33371)
Editorial (11)
Employer branding (5)
Employer resources (47)
Events (40117)
Executive appointments (368)
FDA (7217)
Featured Employer (23)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (225)
Gene editing (41)
Generative AI (8)
Gene therapy (111)
GLP-1 (346)
Government (1368)
Grass and pollen (2)
Guidances (19)
Healthcare (4396)
Huntington's disease (5)
IgA nephropathy (10)
Immunology and inflammation (36)
Indications (13)
Infectious disease (871)
Inflammatory bowel disease (61)
Inflation Reduction Act (6)
Influenza (19)
Intellectual property (48)
Interviews (64)
IPO (6232)
IRA (29)
Job creations (2083)
Job search strategy (394)
Kidney cancer (6)
Labor market (10)
Layoffs (183)
Leadership (3)
Legal (3488)
Liver cancer (19)
Lung cancer (104)
Lymphoma (62)
Machine learning (1)
Management (18)
Manufacturing (142)
MASH (31)
Medical device (1701)
Medtech (1703)
Mergers & acquisitions (10073)
Metabolic disorders (256)
Multiple sclerosis (20)
NASH (15)
Neurodegenerative disease (22)
Neuropsychiatric disorders (6)
Neuroscience (611)
NextGen: Class of 2025 (1790)
Non-profit (776)
Northern California (737)
Now hiring (7)
Obesity (144)
Opinion (120)
Ovarian cancer (21)
Pain (52)
Pancreatic cancer (24)
Parkinson's disease (44)
Partnered (7)
Patents (109)
Patient recruitment (30)
Peanut (10)
People (29817)
Pharmaceutical (66)
Pharmacy benefit managers (11)
Phase I (8634)
Phase II (13941)
Phase III (12294)
Pipeline (435)
Podcasts (48)
Policy (60)
Postmarket research (1425)
Preclinical (3567)
Press Release (29)
Prostate cancer (47)
Psychedelics (8)
Radiopharmaceuticals (127)
Rare diseases (172)
Real estate (2737)
Recruiting (18)
Regulatory (10542)
Reports (14)
Research institute (656)
Resumes & cover letters (57)
Rett syndrome (1)
RNA editing (2)
RSV (7)
Schizophrenia (38)
Series A (39)
Series B (12)
Service/supplier (3)
Sickle cell disease (31)
Southern California (739)
Special edition (6)
Spinal muscular atrophy (91)
Sponsored (8)
Startups (1718)
State (2)
Stomach cancer (3)
Supply chain (31)
The Weekly (30)
United States (7648)
Vaccines (165)
Venture capitalists (13)
Webinars (10)
Weight loss (97)
Women's health (9)
Worklife (3)
Date
Today (95)
Last 7 days (280)
Last 30 days (1074)
Last 365 days (13246)
2025 (3256)
2024 (13756)
2023 (15533)
2022 (21201)
2021 (21738)
2020 (20714)
2019 (16569)
2018 (12738)
2017 (14706)
2016 (13929)
2015 (16358)
2014 (13029)
2013 (11116)
2012 (11859)
2011 (12381)
2010 (11255)
Location
Africa (332)
Alabama (15)
Alaska (1)
Arizona (58)
Arkansas (4)
Asia (20867)
Australia (2721)
California (1775)
Canada (907)
China (236)
Colorado (69)
Connecticut (70)
Delaware (57)
Europe (41145)
Florida (382)
Georgia (40)
Idaho (13)
Illinois (207)
India (14)
Indiana (131)
Iowa (1)
Japan (87)
Kansas (55)
Kentucky (13)
Maine (2)
Maryland (273)
Massachusetts (1523)
Michigan (49)
Minnesota (92)
Missouri (24)
Montana (10)
Nebraska (6)
Nevada (9)
New Hampshire (9)
New Jersey (810)
New Mexico (8)
New York (604)
North Carolina (391)
North Dakota (2)
Northern California (737)
Ohio (52)
Oklahoma (4)
Oregon (16)
Pennsylvania (447)
Puerto Rico (8)
Rhode Island (7)
South America (529)
South Carolina (2)
Southern California (739)
Tennessee (34)
Texas (288)
Utah (35)
Virginia (70)
Washington D.C. (32)
Washington State (135)
Wisconsin (15)
281,828 Results for "spectrum pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spectrum Dynamics Medical Appoints Tomer Gabay as its New Chief Executive Officer
March 14, 2025
·
1 min read
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
Press Releases
Autism Spectrum Disorder Markets Expected to Exhibit a CAGR Of 5.84% During 2025-2035, impelled by Innovative Treatments
February 13, 2025
·
10 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes Influenza A viruses, possibly including Bird Flu H5N1 virus as well.
May 6, 2024
·
8 min read
Press Releases
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
March 7, 2025
·
5 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes activity against orthopoxvirus family, with both inhalation and skin abrasion modes of infection acquisition.
May 8, 2024
·
8 min read
Press Releases
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
October 8, 2024
·
7 min read
Drug Development
Osivax Completes Enrollment for Phase 1 Trial with Broad-Spectrum Sarbecovirus Vaccine Candidate, OVX033
Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, announced that it has completed enrollment in its Phase 1 trial with OVX033, the company’s broad-spectrum vaccine candidate against sarbecoviruses.
June 25, 2024
·
3 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against RSV
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV-387 against RSV/A2 is strong enough to have resulted in full survival of lethally infected animals was achieved.
May 14, 2024
·
7 min read
Pharm Country
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
NanoViricides, Inc., a clinical stage global leader in broad-spectrum antiviral nanomedicines, comments that the ultra-broad-spectrum antiviral NV-387 could be an important weapon against bird flu H5N1 viruses.
June 24, 2024
·
8 min read
1 of 28,183
Next
